Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first ...

Minds + Assembly, a 2024 MM+M Agency 100 honoree, added Chuck Hemann as chief integration officer and Jonathan Woodring as ...

Tonix Pharmaceuticals (NASDAQ: TNXP) announced that its President and CEO, Seth Lederman, M.D., will present at the BIO CEO & Investor Conference on ...

Tonix Pharmaceuticals saw its shares swing wildly between gains and losses on Wednesday morning as they started to trade ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products ...

The stock markets in the US opened higher on February 4 as investors remained cautious about China’s stance on the Trump ...

EST Tonix Pharmaceuticals (TNXP) trading halted, news pendingMaximize Your Portfolio with Data Driven Insights:Leverage the power of ...

Tonix Pharmaceuticals (NASDAQ: TNXP) announced the promotion of Siobhan Fogarty to chief technical officer. Fogarty, who joined Tonix in 2016, previo ...

CHATHAM, N.J. - Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), a biopharmaceutical company with a market capitalization ...

Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product Development Tonix is Preparing for Potential Launch of TNX-102 SL for the management of fibromyalgia with ...

Tonix Pharmaceuticals (TNXP) stock plunged after the company carried out a 1-for-100 reverse stock split as it awaits approval for its ...